World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
125
Citations
65116
World Ranking
278
National Ranking
178

Medicine

D-Index
125
Citations
65324
World Ranking
3061
National Ranking
1690

Frederick G. Hayden publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Frederick G. Hayden sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 351 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Frederick G. Hayden D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Frederick G. Hayden sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 125 D-Index — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Frederick G. Hayden is affiliated with the University of Virginia in the United States. Their research primarily focuses on medicine, with a significant number of publications in epidemiology and infectious diseases. Additional subfields include neurology, cardiology and cardiovascular medicine, and genetics.

Their work covers major topics related to viral infections and immunological responses, especially in the context of respiratory diseases. Key research areas include:

  • Influenza Virus Research Studies
  • Respiratory Viral Infections Research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Long-Term Effects of COVID-19
  • Viral Infections and Immunology Research
  • Viral Infections and Outbreaks Research

Frederick G. Hayden's recent publications demonstrate engagement with emerging infectious diseases, particularly COVID-19. Selected papers include:

  • A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19 (2020, New England Journal of Medicine)
  • Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial (2020, The Lancet)
  • Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) (2020, Intensive Care Medicine)
  • Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update (2021, Critical Care Medicine)
  • Critical care management of adults with community-acquired severe respiratory viral infection (2020, Intensive Care Medicine)

Frequent collaborators in Frederick G. Hayden's research include Bin Cao, Yaseen M. Arabi, Yeming Wang, Guohui Fan, and Peter Horby. These co-authors have contributed jointly on multiple occasions, reflecting collaborative research efforts in the areas of infectious diseases and critical care.

Their work has appeared predominantly in journals specializing in infectious diseases and critical care, with frequent publications in:

  • The Journal of Infectious Diseases
  • New England Journal of Medicine
  • The Lancet
  • Intensive Care Medicine
  • Trials

Best Publications

  • A novel coronavirus outbreak of global health concern.

    Chen Wang;Peter W Horby;Frederick G Hayden;George F Gao

  • Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.

    Yeming Wang;Yeming Wang;Dingyu Zhang;Guanhua Du;Ronghui Du

  • Avian influenza A (H5N1) infection in humans

    John H Beigel;Jeremy Farrar;Aye Maung Han;Frederick G Hayden

  • Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection.

    Bautista E;Chotpitayasunondh T;Gao Z

  • Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza

    John J. Treanor;Frederick G. Hayden;Peter S. Vrooman;Rick Barbarash

  • Corticosteroid Therapy for Critically Ill Patients With Middle East Respiratory Syndrome

    Arabi Ym;Mandourah Y;Al-Hameed F;Sindi Aa

  • The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in Children

    Robert B. Belshe;Paul M. Mendelman;John Treanor;James King

  • Resistant influenza A viruses in children treated with oseltamivir: descriptive study

    Maki Kiso;Keiko Mitamura;Yuko Sakai-Tagawa;Kyoko Shiraishi

  • Influenza virus neuraminidase inhibitors

    Larisa V Gubareva;Laurent Kaiser;Frederick G Hayden

  • Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense.

    F. G. Hayden;R. S. Fritz;M. C. Lobo;W. G. Alvord

  • Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents

    Hayden Fg;Sugaya N;Hirotsu N;Lee N

  • Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections

    Frederick G. Hayden;Albert D.M.E. Osterhaus;John J. Treanor;Douglas M. Fleming

  • Kinetics of Influenza A Virus Infection in Humans

    Prasith Baccam;Catherine Beauchemin;Catherine A. Macken;Frederick G. Hayden

  • Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America

    Scott A. Harper;John S. Bradley;Janet A. Englund;Thomas M. File

  • Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.

    F G Hayden;J J Treanor;R S Fritz;M Lobo

  • Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.

    Laurent Kaiser;Cynthia Wat;Tracy Mills;Paul Mahoney

  • Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.

    Frederick G. Hayden;Robert L. Atmar;Margo Schilling;Casey Johnson

  • Influenza vaccination of health care workers in hospitals - a review of studies on attitudes and predictors.

    Helge G. Hollmeyer;Frederick Hayden;Gregory Poland;Udo Buchholz

  • Nonpharmaceutical interventions for pandemic influenza, national and community measures

    Angus Nicoll;Angus Nicoll;Angus Nicoll;Keiji Fukuda;Peter Horby;Arnold Monto

  • Rhinovirus and Respiratory Syncytial Virus in Wheezing Children Requiring Emergency Care IgE and Eosinophil Analyses

    Gary P. Rakes;Eurico Arruda;Jim M. Ingram;Gates E. Hoover

  • Emergence and apparent transmission of rimantadine-resistant influenza A virus in families

    Frederick G. Hayden;Robert B. Belshe;Richard D. Clover;Alan J. Hay

  • Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.

    Robert B. Belshe;William C. Gruber;Paul M. Mendelman;Iksung Cho

  • Inhaled zanamivir for the prevention of influenza in families

    Frederick G. Hayden;Larisa V. Gubareva;Arnold S. Monto;Thomas C. Klein

Frequent Co-Authors

Jack M. Gwaltney
Jack M. Gwaltney University of Virginia
Yaseen M. Arabi
Yaseen M. Arabi King Saud bin Abdulaziz University for Health Sciences
Robert A. Fowler
Robert A. Fowler Sunnybrook Health Science Centre
John J. Treanor
John J. Treanor University of Rochester Medical Center
Robert G. Webster
Robert G. Webster St. Jude Children's Research Hospital
Maria Zambon
Maria Zambon Public Health England
Peter Horby
Peter Horby University of Oxford
Richard J. Whitley
Richard J. Whitley University of Alabama at Birmingham
David S.C. Hui
David S.C. Hui Chinese University of Hong Kong
Jeremy Farrar
Jeremy Farrar World Health Organization

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying immunology in the USA opens doors to various healthcare and research careers. For those interested in nursing, exploring programs with accessible entry points can be crucial. Many aspiring nurses seek the easiest accelerated nursing programs to get into, offering a faster route to becoming a Registered Nurse (RN) without compromising quality education.

If you prefer starting with practical nursing, researching which LPN programs are easiest to get into can help you find suitable options that ease the admission process. Licensed Practical Nurses often work alongside immunologists in clinical settings, providing essential patient care.

For advanced practice roles, nurse practitioner programs with easy admission present opportunities to expand clinical expertise and specialize in fields like immunology. These programs balance accessibility with advanced training essentials.

Additionally, mental health remains integral to immunological health, making online PMHNP programs with clinical placement highly valuable for students seeking practical experience alongside theoretical knowledge.

Best Scientists Citing Frederick G. Hayden

Trending Scientists